CNMD Stock Analysis: Buy, Sell, or Hold?
CNMD - CONMED Corporation
$32.54
-0.04 (-0.12%)
▼
5d:
-6.41%
30d:
-12.08%
90d:
-9.46%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When CNMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CNMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.63
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$33.92
4.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNMD is currently trading at $32.54, which is considered oversold relative to its 30-day fair value range of $33.64 to $36.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.8) compared to its historical average (8.2). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 136.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CNMD is in a strong downtrend. Immediate support is located at $31.44, while resistance sits at $37.48.
Market Sentiment: CNMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $39.60 (+21.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNMD is in a strong downtrend. Immediate support is located at $31.44, while resistance sits at $37.48.
Market Sentiment: CNMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $39.60 (+21.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$33.64 -
$36.52
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.7% below Wall St target ($39.60)
- CAUTION: 5-day price weakness (-6.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$33.64 -
$36.52
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$31.44
Resistance Level
$37.48
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.80
Wall Street Target
$39.60
(+21.7%)
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
136.8%
Profit Margin
4.0%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
6.8 vs 8.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$30.62
(-6%)
2-Year Target
$28.81
(-12%)
3-Year Target
$27.11
(-17%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$32.71
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.7%)
$137.62
(+323%)
Base:
(SPY PE: 6.8, Growth: 9.7%)
$42.94
(+32%)
Bear:
(PE: 5.8, Growth: 9.7%)
$36.50
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 18.41 | Current EPS (TTM): $1.77
Bull Case
$71.68
(+120%)
Analyst growth 100.0%, PE expands to 20.3
Base Case
$65.16
(+100%)
Market implied 100.0%, PE stable at 18.4
Bear Case
$22.15
(-32%)
Severe decline -20.0%, PE contracts to 15.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.8 to 8.2
Stabilization Target:
$39.26
(+20.7%)
PE Expansion Potential:
+20.7%
Share & Embed Analysis
Last updated: June 23, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
